BR112016002650A2 - probiótico para choro excessivo infantil - Google Patents

probiótico para choro excessivo infantil

Info

Publication number
BR112016002650A2
BR112016002650A2 BR112016002650A BR112016002650A BR112016002650A2 BR 112016002650 A2 BR112016002650 A2 BR 112016002650A2 BR 112016002650 A BR112016002650 A BR 112016002650A BR 112016002650 A BR112016002650 A BR 112016002650A BR 112016002650 A2 BR112016002650 A2 BR 112016002650A2
Authority
BR
Brazil
Prior art keywords
probiotic
bacterial composition
excessive
composition
pediococcus pentosaceus
Prior art date
Application number
BR112016002650A
Other languages
English (en)
Portuguese (pt)
Inventor
Lázaro Mallén Elisabet
Cuñé Castellana Jordi
Espadaler Mazo Jordi
Original Assignee
Ab Biotics Sa
Venpharma Laboratorios S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Biotics Sa, Venpharma Laboratorios S A filed Critical Ab Biotics Sa
Publication of BR112016002650A2 publication Critical patent/BR112016002650A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/206Bacterial extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/41Pediococcus
    • A23V2400/427Pentosaceus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pediatric Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112016002650A 2013-08-09 2014-08-07 probiótico para choro excessivo infantil BR112016002650A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13382324 2013-08-09
PCT/EP2014/066970 WO2015018883A2 (en) 2013-08-09 2014-08-07 Probiotic for infantile excessive crying

Publications (1)

Publication Number Publication Date
BR112016002650A2 true BR112016002650A2 (pt) 2017-09-12

Family

ID=49029044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016002650A BR112016002650A2 (pt) 2013-08-09 2014-08-07 probiótico para choro excessivo infantil

Country Status (17)

Country Link
US (2) US10265351B2 (ja)
EP (1) EP3030247B1 (ja)
JP (1) JP6643988B2 (ja)
KR (1) KR102084825B1 (ja)
CN (2) CN105555283B (ja)
AU (1) AU2014304535B2 (ja)
BR (1) BR112016002650A2 (ja)
CA (2) CA3176938A1 (ja)
DK (1) DK3030247T3 (ja)
EA (1) EA034531B9 (ja)
ES (1) ES2683190T3 (ja)
HU (1) HUE039336T2 (ja)
MX (2) MX2016001635A (ja)
PH (1) PH12016500271A1 (ja)
PL (1) PL3030247T3 (ja)
TW (1) TW201536302A (ja)
WO (1) WO2015018883A2 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
CN110520142A (zh) * 2017-05-05 2019-11-29 雀巢产品有限公司 婴儿腹绞痛的治疗
JP6836756B2 (ja) * 2017-09-21 2021-03-03 光博 岡野 口腔細菌叢中の構成叢比を予測する方法
CN111902530A (zh) 2017-11-10 2020-11-06 阿米蒂比奥有限公司 新型戊糖片球菌ab160011菌株及包含其的组合物
KR102434641B1 (ko) * 2018-11-23 2022-08-23 한국식품연구원 페디오코쿠스 펜토사세우스를 이용한 호흡기 기능 개선용 식품 조성물
WO2021231504A1 (en) * 2020-05-12 2021-11-18 Rpi Consulting Llc Systems and methods for isolating and testing blood for biomarkers and genetic material
EP4370141A1 (en) 2021-07-13 2024-05-22 AB-Biotics, S.A. Probiotic composition for the treatment of increased intestinal permeability
WO2023170680A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
SE0400355D0 (sv) 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
EP2114423B2 (en) * 2007-02-28 2020-01-01 MJN U.S. Holdings LLC Inactivated lactobacillus rhammosus gg for treating systemic inflammation in infants
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
JP5531321B2 (ja) * 2009-03-31 2014-06-25 キッコーマン株式会社 Il−10産生促進作用を有する免疫賦活組成物
TWI415942B (zh) * 2009-10-15 2013-11-21 Food Industry Res & Dev Inst 生產胞外多醣的方法以及一新穎的乳酸小球菌分離株
WO2011069987A1 (en) * 2009-12-08 2011-06-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
CA3167205A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes

Also Published As

Publication number Publication date
US20180008652A1 (en) 2018-01-11
CN105555283B (zh) 2020-08-11
CN111676171A (zh) 2020-09-18
MX2016001635A (es) 2016-10-07
AU2014304535A1 (en) 2016-03-10
CN105555283A (zh) 2016-05-04
JP6643988B2 (ja) 2020-02-12
CN111676171B (zh) 2023-06-06
EA201690196A1 (ru) 2016-12-30
MX2021000259A (es) 2021-03-25
CA3176938A1 (en) 2015-02-12
JP2016526918A (ja) 2016-09-08
EA034531B1 (ru) 2020-02-18
WO2015018883A2 (en) 2015-02-12
AU2014304535B2 (en) 2017-06-15
EP3030247A2 (en) 2016-06-15
WO2015018883A3 (en) 2015-04-02
PL3030247T3 (pl) 2019-02-28
PH12016500271A1 (en) 2016-05-16
DK3030247T3 (en) 2018-08-13
HUE039336T2 (hu) 2018-12-28
KR102084825B1 (ko) 2020-03-04
US10265351B2 (en) 2019-04-23
EP3030247B1 (en) 2018-05-16
CA2920461A1 (en) 2015-02-12
ES2683190T3 (es) 2018-09-25
US20160184371A1 (en) 2016-06-30
EA034531B9 (ru) 2020-03-19
TW201536302A (zh) 2015-10-01
CA2920461C (en) 2023-01-03
KR20160046826A (ko) 2016-04-29

Similar Documents

Publication Publication Date Title
BR112016002650A2 (pt) probiótico para choro excessivo infantil
CY1117183T1 (el) Διακλαδισμενα παραγωγα 3-φαινυλοπροπιονικου οξεος και η χρηση τους
BR112013016929A2 (pt) oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
BR112013028705A2 (pt) cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes
BR112013016936A2 (pt) métodos de usar oligossacarídeos de leite humano para melhorar a saúde respiratória das vias aéreas
CO2018002394A2 (es) Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa
RU2015122495A (ru) Содержащие треонат магния питательные композиции и их применение
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
MY175195A (en) Nutritional compositions
EA201300243A1 (ru) Продукт для верхнего отдела желудочно-кишечного тракта
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
BR112014004123A2 (pt) micro-organismos das espécies bacteroides xylanisolvens
EA201291405A1 (ru) Продукт, содержащий катехины
JP2015533484A5 (ja)
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso
MX2015004577A (es) Suplemento nutricional para pacientes con enfermedades reumaticas.
MX2012006534A (es) Composicion de fructo-oligosacaridos e inulina de agave de alta pureza con un probiotico y sus usos.
BR112014015193A8 (pt) composição enriquecida com glicoproteína como um aditivo para alimento e/ou ração e/ou como um agente terapêutico
PL401911A1 (pl) Zastosowanie preparatu o wlasciwosciach immunoregulatorowych
CN301686058S (zh) 发电机组
CN302439953S (zh) 包装盒(蛋糕)
TH135371B (th) เก้าอี้
TH122048B (th) แผ่นรองฝ่าเท้า

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/74 (2015.01), A61P 1/00 (2006.01)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]